Cite
HARVARD Citation
Li, M. et al. (2021). Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers. Clinical pharmacology in drug development. 10 (6), pp. 634-646. [Online].